Pharma-Funded Pilot To Improve Adherence, Lower Readmissions Gets OIG Nod
Executive Summary
Medicare Advantage plans might eventually use toolkit being developed by the Academy of Managed Care Pharmacy, which is a partner in the initiative.
You may also be interested in...
Value-Based Contracts Getting More Safe Harbor Attention From OIG
But so far, OIG has declined a blanket safe harbor for proposed value-based payments, saying it still wants to consider proposals case-by-case. Discussions between the office and stakeholders are continuing, Bristol-Myers Squibb's Mike Ryan says.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.